M&A · Healthcare · Biological Products, (No Diagnostic Substances)
Concentra Biosciences, LLC to acquire Elevation Oncology, Inc.
Announced Jun 9, 2025 · Closed Jul 23, 2025
Deal value$21M
Premium12.5%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$0.36 per share
Transaction
- Acquirer
- Concentra Biosciences, LLC
- Target
- Elevation Oncology, Inc. (ELEV)
- Buyer type
- Private equity
- Offer price per share
- $0.36
- Enterprise value
- —
- Status
- Closed Jul 23, 2025
Deal protections
- Break fee (target pays)
- $1.2M · 5.6%
- Reverse fee (buyer pays)
- —
- Go-shop
- —
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Sector context · Healthcare
- Comparable deals
- 91 in the prior 24 months
- Premium
- 12.5% vs. 67.0% sector median
- EV / Adj. EBITDA
- Sector median 14.5x
- Break fee
- 5.6% vs. 3.5% sector median
Timeline
- AnnouncedJun 9, 2025
- Tender offerJun 23, 2025
- ClosedJul 23, 2025
Valuation · fairness opinions
Discounted cash flow$0.30$0.39
Other analysis$0.32$0.37
Offer $0.36
Implied value per Elevation Oncology, Inc. share by analysis.